GRAIL, Inc. Common Stock (GRAL)

• Market cap: $459M
• 1 day: 5.64%
• 5 days: -0.40%
• 1 month: 2.07%
• 3 months: -11.91%
• 6 months: 8.27%
• Year to date: 8.27%
• 1 year: 8.27%
• 5 years: 8.27%
• 10 years: 8.27%
• Sector: Healthcare
• Industry: Medical Laboratories

About: GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2% more call options, than puts

Call options by funds: $3.32M | Put options by funds: $3.24M

2.32% less ownership

Funds ownership: 72.53% [Q2] → 70.21% (-2.32%) [Q3]

17% less funds holding

Funds holding: 357 [Q2] → 298 (-59) [Q3]

20% less capital invested

Capital invested by funds: $347M [Q2] → $278M (-$68.4M) [Q3]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]

40% less first-time investments, than exits

New positions opened: 90 | Existing positions closed: 149

54% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 108